Author: CIMS Global
-
CIMS Unveils Dynamic Data Monitoring and Dynamic Trial Design at SCOPE 2019
[vc_row][vc_column][vc_column_text css=”.vc_custom_1555864818027{margin-bottom: 0px !important;}”]CIMS is proud to introduce its AI-engineered statistical package and full suite of eClinical offerings at SCOPE 2019 in Orlando. Called Dynamic Data Monitoring (DDM), this one-of-a-kind, patented DDM platform utilizes machine learning and artificial intelligence to dynamically monitor and optimize your clinical trial. With the CIMS closed system, you can typically…
-
Reshaping the Future of Clinical Trials
[vc_row][vc_column][vc_column_text css=”.vc_custom_1555864690658{margin-bottom: 0px !important;}”]The traditional method for evaluating clinical trial data in phase 2 and phase 3 studies requires sponsors to collect enough data to support an Independent Data Monitoring Committee (IDMC) review. Over half of these results are negative, causing sponsors to waste valuable time and millions in lengthy clinical trials. The FDA has…